First-time women principal investigator scientists received considerably less funding from the National Institutes of Health compared to first-time male principal investigators, reports a new Northwestern study published in JAMA.
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.